- The author is exhausted from answering pandemic questions, debunking rumors, and is taking a short break.
- Vaccine effectiveness will be judged by Israel's results, potentially reframing COVID-19 as a 'bad flu' or dashing optimism.
- Outcomes of Johnson & Johnson and AstraZeneca vaccine trials will significantly impact vaccination efforts and public mood.
- COVID-19 mutations could increase spread or escape immunity, requiring stricter measures or revaccination.
- Spring weather might reduce transmission, buying time for vaccine production, but this is not guaranteed.
- Medicinal breakthroughs and rapid testing acceptance could be game changers for treatment and event safety.